Matches in SemOpenAlex for { <https://semopenalex.org/work/W2970769806> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2970769806 endingPage "e52" @default.
- W2970769806 startingPage "e48" @default.
- W2970769806 abstract "Abstract Background Patients with advanced lung neuroendocrine neoplasms (NENs) have few treatment options. Capecitabine and temozolomide have recently showed significant activity in patients with pancreatic neuroendocrine tumors (NETs), but data in lung NETs are limited. Methods We retrospectively reviewed the records of patients treated at a large referral center to identify patients seen between January 2008 and September 2018 with metastatic lung NENs who received treatment with capecitabine and temozolomide (CAPTEM). Patients with small cell lung cancer were excluded. The primary endpoint was overall response rate per RECIST 1.1. Secondary endpoints included progression-free survival, overall survival, and toxicity. Results Twenty patients were identified who received treatment with capecitabine and temozolomide. Fourteen (70%) had typical lung NETs, five had (25%) atypical carcinoids, and one (5%) had disease defined as a large-cell neuroendocrine carcinoma. Nineteen patients were evaluable for response. Six (30%) patients exhibited a best response of partial response per RECIST 1.1 criteria, 11 (55%) stable disease, and 2 (10%) progressive disease; objective response rate was 30%, and disease control rate was 85%. Eleven patients eventually progressed, only six of whom exhibited progression per RECIST 1.1 criteria. Median progression-free survival was 13 months (95% confidence interval [CI], 4.4–21.6 months). Median overall survival was 68 months (95% CI, 35.3–100.7 months). Toxicity profile was mild with mainly grade 1, expected toxicities. Six patients required dose reduction because of toxicity. Conclusion The CAPTEM regimen is associated with a high response rate and a relatively tolerable toxicity profile in lung NENs. This regimen warrants further exploration in a prospective clinical trial." @default.
- W2970769806 created "2019-09-05" @default.
- W2970769806 creator A5014471689 @default.
- W2970769806 creator A5056536269 @default.
- W2970769806 creator A5068503288 @default.
- W2970769806 date "2019-08-27" @default.
- W2970769806 modified "2023-10-14" @default.
- W2970769806 title "Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms" @default.
- W2970769806 cites W2011916383 @default.
- W2970769806 cites W2090232354 @default.
- W2970769806 cites W2101433894 @default.
- W2970769806 cites W2163703503 @default.
- W2970769806 cites W2164118670 @default.
- W2970769806 cites W2209368665 @default.
- W2970769806 cites W2251438188 @default.
- W2970769806 cites W2512663019 @default.
- W2970769806 cites W2765867855 @default.
- W2970769806 cites W2808537568 @default.
- W2970769806 cites W4235705773 @default.
- W2970769806 doi "https://doi.org/10.1634/theoncologist.2019-0361" @default.
- W2970769806 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6964126" @default.
- W2970769806 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31455747" @default.
- W2970769806 hasPublicationYear "2019" @default.
- W2970769806 type Work @default.
- W2970769806 sameAs 2970769806 @default.
- W2970769806 citedByCount "35" @default.
- W2970769806 countsByYear W29707698062019 @default.
- W2970769806 countsByYear W29707698062020 @default.
- W2970769806 countsByYear W29707698062021 @default.
- W2970769806 countsByYear W29707698062022 @default.
- W2970769806 countsByYear W29707698062023 @default.
- W2970769806 crossrefType "journal-article" @default.
- W2970769806 hasAuthorship W2970769806A5014471689 @default.
- W2970769806 hasAuthorship W2970769806A5056536269 @default.
- W2970769806 hasAuthorship W2970769806A5068503288 @default.
- W2970769806 hasBestOaLocation W29707698061 @default.
- W2970769806 hasConcept C121608353 @default.
- W2970769806 hasConcept C126322002 @default.
- W2970769806 hasConcept C141071460 @default.
- W2970769806 hasConcept C143998085 @default.
- W2970769806 hasConcept C203092338 @default.
- W2970769806 hasConcept C2776256026 @default.
- W2970769806 hasConcept C2776694085 @default.
- W2970769806 hasConcept C2777389519 @default.
- W2970769806 hasConcept C2777909004 @default.
- W2970769806 hasConcept C2778822529 @default.
- W2970769806 hasConcept C2779066768 @default.
- W2970769806 hasConcept C2779984678 @default.
- W2970769806 hasConcept C2780739268 @default.
- W2970769806 hasConcept C2781413609 @default.
- W2970769806 hasConcept C526805850 @default.
- W2970769806 hasConcept C535046627 @default.
- W2970769806 hasConcept C71924100 @default.
- W2970769806 hasConcept C90924648 @default.
- W2970769806 hasConceptScore W2970769806C121608353 @default.
- W2970769806 hasConceptScore W2970769806C126322002 @default.
- W2970769806 hasConceptScore W2970769806C141071460 @default.
- W2970769806 hasConceptScore W2970769806C143998085 @default.
- W2970769806 hasConceptScore W2970769806C203092338 @default.
- W2970769806 hasConceptScore W2970769806C2776256026 @default.
- W2970769806 hasConceptScore W2970769806C2776694085 @default.
- W2970769806 hasConceptScore W2970769806C2777389519 @default.
- W2970769806 hasConceptScore W2970769806C2777909004 @default.
- W2970769806 hasConceptScore W2970769806C2778822529 @default.
- W2970769806 hasConceptScore W2970769806C2779066768 @default.
- W2970769806 hasConceptScore W2970769806C2779984678 @default.
- W2970769806 hasConceptScore W2970769806C2780739268 @default.
- W2970769806 hasConceptScore W2970769806C2781413609 @default.
- W2970769806 hasConceptScore W2970769806C526805850 @default.
- W2970769806 hasConceptScore W2970769806C535046627 @default.
- W2970769806 hasConceptScore W2970769806C71924100 @default.
- W2970769806 hasConceptScore W2970769806C90924648 @default.
- W2970769806 hasIssue "1" @default.
- W2970769806 hasLocation W29707698061 @default.
- W2970769806 hasLocation W29707698062 @default.
- W2970769806 hasLocation W29707698063 @default.
- W2970769806 hasLocation W29707698064 @default.
- W2970769806 hasOpenAccess W2970769806 @default.
- W2970769806 hasPrimaryLocation W29707698061 @default.
- W2970769806 hasRelatedWork W1596193789 @default.
- W2970769806 hasRelatedWork W2008997722 @default.
- W2970769806 hasRelatedWork W2026218969 @default.
- W2970769806 hasRelatedWork W2396364698 @default.
- W2970769806 hasRelatedWork W2468894750 @default.
- W2970769806 hasRelatedWork W2512663019 @default.
- W2970769806 hasRelatedWork W2590094134 @default.
- W2970769806 hasRelatedWork W2899728500 @default.
- W2970769806 hasRelatedWork W3008747135 @default.
- W2970769806 hasRelatedWork W3158956181 @default.
- W2970769806 hasVolume "25" @default.
- W2970769806 isParatext "false" @default.
- W2970769806 isRetracted "false" @default.
- W2970769806 magId "2970769806" @default.
- W2970769806 workType "article" @default.